Exploring molecular phenotypes of incident breast cancer through population-based proteogenomics
Proteins play key roles in malignant transformation and represent an important hub for oncogenic signaling. Elevated levels of circulating proteins could potentially be identified years before the onset of cancer and its detection by current diagnostics. This webinar will focus on exploring the power of proteomic discoveries, at the population scale in a breast cancer cohort, and the integration of proteogenomics to generate key biological insights into risk prediction that may lead to translational applications for breast cancer prevention.
Join this expert webinar to learn more about:
- The importance of integrating multi-omics at a systemic level to generate key biological insights for cancer prevention, diagnosis, and treatment
- Emerging large-scale cancer proteomics analyses at the population level
- Using high-throughput proteomics to find actionable biomarkers to better understand and treat human cancer
Who should attend:
Academic, clinical or pharma industry scientists who would like to know how high-throughput proteomics is being applied together with other omics approaches to find actionable biomarkers to better understand and treat human cancer.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.